In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause unpleasant skin reactions ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Along with other actions, RFK’s move on mRNA paints a portrait of a longtime vaccine skeptic pursuing exactly the agenda he ...

Robert F. Kennedy Jr.’s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA ...